225 related articles for article (PubMed ID: 15815943)
21. Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats.
Li Y; McMartin KE
Am J Physiol Renal Physiol; 2009 May; 296(5):F1080-7. PubMed ID: 19244400
[TBL] [Abstract][Full Text] [Related]
22. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
23. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
[TBL] [Abstract][Full Text] [Related]
24. Tubular and interstitial nephrocalcinosis.
Kummeling MT; de Jong BW; Laffeber C; Kok DJ; Verhagen PC; van Leenders GJ; van Schaik RH; van Woerden CS; Verhulst A; Verkoelen CF
J Urol; 2007 Sep; 178(3 Pt 1):1097-103. PubMed ID: 17644134
[TBL] [Abstract][Full Text] [Related]
25. Nephrocalcinosis: molecular insights into calcium precipitation within the kidney.
Sayer JA; Carr G; Simmons NL
Clin Sci (Lond); 2004 Jun; 106(6):549-61. PubMed ID: 15027893
[TBL] [Abstract][Full Text] [Related]
26. A new model of nephrolithiasis involving tubular dysfunction/injury.
Kumar S; Sigmon D; Miller T; Carpenter B; Khan S; Malhotra R; Scheid C; Menon M
J Urol; 1991 Nov; 146(5):1384-9. PubMed ID: 1942307
[TBL] [Abstract][Full Text] [Related]
27. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
[TBL] [Abstract][Full Text] [Related]
28. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
Khan SR; Thamilselvan S
Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
[TBL] [Abstract][Full Text] [Related]
29. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Parker WR; Asplin JR
Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
[TBL] [Abstract][Full Text] [Related]
30. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
[TBL] [Abstract][Full Text] [Related]
31. Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone.
Evan AP; Lingeman JE; Coe FL; Worcester EM
Semin Nephrol; 2008 Mar; 28(2):111-9. PubMed ID: 18359392
[TBL] [Abstract][Full Text] [Related]
32. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
Robertson WG
Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
[TBL] [Abstract][Full Text] [Related]
33. Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles.
Kumar V; Farell G; Yu S; Harrington S; Fitzpatrick L; Rzewuska E; Miller VM; Lieske JC
J Investig Med; 2006 Nov; 54(7):412-24. PubMed ID: 17169263
[TBL] [Abstract][Full Text] [Related]
34. [Calcium oxalate stone formation. New pathogenetic aspects of an old disease].
Wendt-Nordahl G; Evan AP; Spahn M; Knoll T
Urologe A; 2008 May; 47(5):538, 540-44. PubMed ID: 18392604
[TBL] [Abstract][Full Text] [Related]
35. Dietary oxalate and calcium oxalate nephrolithiasis.
Khan SR; Glenton PA; Byer KJ
J Urol; 2007 Nov; 178(5):2191-6. PubMed ID: 17870111
[TBL] [Abstract][Full Text] [Related]
36. Deposition of calcium phosphate and calcium oxalate crystals in the kidneys.
Khan SR; Glenton PA
J Urol; 1995 Mar; 153(3 Pt 1):811-7. PubMed ID: 7861545
[TBL] [Abstract][Full Text] [Related]
37. A case of nephrocalcinosis associated with primary aldosteronism.
Yasuda K; Sasaki K; Yamato M; Rakugi H; Isaka Y; Hayashi T
Intern Med; 2012; 51(6):625-7. PubMed ID: 22449672
[TBL] [Abstract][Full Text] [Related]
38. Influence of nifedipine on stone formation and renal function in cholesterol-induced nephrolithiasis in rats.
Strohmaier WL; Witte B; Nelde HJ
Urol Int; 1994; 52(2):87-92. PubMed ID: 8178383
[TBL] [Abstract][Full Text] [Related]
39. [Effect of calcium antagonists (nifedipine) on nephrocalcinosis and calcium excretion in the rat].
Bichler KH; Strohmaier WL; Schanz F; Nelde HJ; Gaiser I; Schulze E; Schreiber M
Urol Int; 1985; 40(1):13-21. PubMed ID: 3976086
[TBL] [Abstract][Full Text] [Related]
40. The protective role of eicosapentaenoic acid [EPA] in the pathogenesis of nephrolithiasis.
Buck AC; Davies RL; Harrison T
J Urol; 1991 Jul; 146(1):188-94. PubMed ID: 2056589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
